University of Oklahoma College of Medicine Researchers Make Discovery About Pancreatic Cancer Drug Resistance
June 03, 2020
June 03, 2020
OKLAHOMA CITY, Oklahoma, June 3 -- The University of Oklahoma's College of Medicine issued the following news:
One of the biggest barriers in treating pancreatic cancer is that it becomes resistant to chemotherapy and its rapid growth cannot be stopped.
Researchers at the OU College of Medicine have published a paper in Gastroenterology, a top journal in GI cancer research, identifying a protein that affects how much chemotherapy can travel into a cancer cell.
One of the biggest barriers in treating pancreatic cancer is that it becomes resistant to chemotherapy and its rapid growth cannot be stopped.
Researchers at the OU College of Medicine have published a paper in Gastroenterology, a top journal in GI cancer research, identifying a protein that affects how much chemotherapy can travel into a cancer cell.